States / Ohio / HB 263

HB 263 In Committee

Cap cost sharing for prescription insulin drugs, diabetes devices

Introduced
In Committee
Floor
Crossed Over
Passed
Enacted

To enact section 3902.65 of the Revised Code to cap cost sharing for prescription insulin drugs, diabetes devices, and diabetic ketoacidosis devices.

Chamber
House
Introduced
May 13, 2025
Last action
May 14, 2025 — Referred to committee
Session
136
Momentum
45 · Moderate